site stats

Reshape medical stock

WebDec 22, 2024 · The new CUSIP number for the company’s common stock following the reverse stock split will be 76090R200. About ReShape Lifesciences Inc. ReShape … WebFind the latest ReShape Lifesciences Inc. (RSLS) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the latest ReShape Lifesciences Inc. (RSLS) stock discussion in Yahoo … Discover historical prices for RSLS stock on Yahoo Finance. View daily, weekly or … Find out the direct holders, institutional holders and mutual fund holders for … Description. ReShape Lifesciences Inc., a medical device company, provides … See ReShape Lifesciences Inc. (RSLS) stock analyst estimates, including earnings and … See ReShape Lifesciences Inc. (RSLS) Environment, Social and Governance … Find the latest ReShape Lifesciences Inc. (RSLS) stock quote, history, news and … Find out all the key statistics for ReShape Lifesciences Inc. (RSLS), including …

ReShape Lifesciences Inc. (RSLS) Stock Price Today, News, …

WebApr 11, 2024 · According to the issued ratings of 1 analysts in the last year, the consensus rating for ReShape Lifesciences stock is Buy based on the current 1 buy rating for RSLS. … WebDec 22, 2024 · Health solutions company ReShape Lifesciences ( NASDAQ: RSLS) rose by 4.20% after the company said its board has declared a 1-for-50 reverse stock split, … エルフェンリート 評価 漫画 https://charlesandkim.com

ReShape Lifesciences NasdaqCM:RSLS Stock Report - Simply Wall …

WebApr 11, 2024 · SAN CLEMENTE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that ... WebMar 7, 2024 · SAN CLEMENTE, Calif., March 7, 2024 /PRNewswire/ -- ReShape Lifesciences Inc. (NASDAQ:RSLS), a developer of minimally invasive medical devices to treat obesity and metabolic diseases, today ... WebApr 11, 2024 · April 11, 2024 - 8:30 am. SAN CLEMENTE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for … takoma tree experts

RSLS - Stock Quotes for Reshape Lifesciences Inc. - Webull

Category:Reshape Lifesciences Inc RSLS Stock Quote - NASDAQ

Tags:Reshape medical stock

Reshape medical stock

Stock Market FinancialContent Business Page

WebDec 22, 2024 · SAN CLEMENTE, Calif., Dec. 22, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic … WebApr 13, 2024 · Risk and Volatility. ReShape Lifesciences has a beta of -0.05, meaning that its stock price is 105% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a …

Reshape medical stock

Did you know?

WebApr 11, 2024 · Trading volume for Reshape Lifesciences's stock is 2.3 million as of 13:30 EST. This is 371.7% of its average full-day volume over the last 100 days. The company's … WebApr 11, 2024 · SAN CLEMENTE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the company has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for patent application 16/792,094, …

WebAug 26, 2015 · SAN CLEMENTE, Calif., August 26, 2015 – ReShape Medical ® today announced that it has completed a Series D financing of $38 million led by HealthCor Partners Management, L.P. with participation from Endeavour Vision SA and existing investors, SV Life Sciences, New Leaf Venture Partners, U.S. Venture Partners and Venture … WebMar 23, 2024 · March 23, 2024 at 08:30 AM EDT. SAN CLEMENTE, Calif., March 23, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician …

WebApr 12, 2024 · 1 equities research analysts have issued 12-month price targets for ReShape Lifesciences' stock. Their RSLS share price forecasts range from $1.75 to $1.75. On … WebReShape Medical General Information. Description. Developer of an integrated gastric dual balloon system designed to transform weight loss. The company's dual balloon system is …

WebRSLS Stock Price - ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. Its portfolio includes the Lap-Band …

WebAug 26, 2015 · SAN CLEMENTE, Calif., Aug. 26, 2015 /PRNewswire/ -- ReShape Medical® today announced that it has completed a Series D financing of $38 million led by HealthCor Partners Management, L.P. with ... エルフォルテ羽田ライゼWebApr 11, 2024 · ReShape Lifesciences Inc. shares gained 9.8% to $2.91 after the company said it received a notice of allowance from the U.S. Patent and Trademark Office for its application related to its Obalon ... エルフナイト10プラス 2022WebApr 13, 2024 · ReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offering. SAN CLEMENTE, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- … エルフォルク川崎WebNov 14, 2024 · ReShape Lifesciences Inc. SAN CLEMENTE, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led … takoma adventist hospital greeneville tnエルフォルク 時計WebApr 13, 2024 · Risk and Volatility. ReShape Lifesciences has a beta of -0.05, meaning that its stock price is 105% less volatile than the S&P 500. Comparatively, OrthoPediatrics has a beta of 0.88, meaning that ... エルフの剣士WebApr 13, 2024 · Summary. OrthoPediatrics beats ReShape Lifesciences on 13 of the 13 factors compared between the two stocks. About ReShape Lifesciences (ReShape Lifesciences, Inc. is a medical device company, which focuses on technology to treat obesity and metabolic diseases. エルフォルテ じゃんけん